Osteoarthritis Pain Global Clinical Trials Review, H1, 2016

  • ID: 3673484
  • Clinical Trials
  • Region: Global
  • 264 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Eli Lilly and Company
  • Endo International Plc
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Pfizer Inc.
  • MORE
Osteoarthritis Pain Global Clinical Trials Review, H1, 2016

Summary

Our clinical trial report, “Osteoarthritis Pain Global Clinical Trials Review, H1, 2016" provides an overview of Osteoarthritis Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Osteoarthritis Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using Our proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Eli Lilly and Company
  • Endo International Plc
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Pfizer Inc.
  • MORE
List of Tables

List of Figures

Report Guidance

Clinical Trials by Region

Clinical Trials and Average Enrollment by Country

Top Five Countries Contributing to Clinical Trials in Asia-Pacific

Top Five Countries Contributing to Clinical Trials in Europe

Top Countries Contributing to Clinical Trials in North America

Top Countries Contributing to Clinical Trials in Middle East and Africa

Top Countries Contributing to Clinical Trials in Central and South America

Clinical Trials by G7 Countries: Proportion of Osteoarthritis Pain to Central Nervous System Clinical Trials

Clinical Trials by Phase in G7 Countries

Clinical Trials in G7 Countries by Trial Status

Clinical Trials by E7 Countries: Proportion of Osteoarthritis Pain to Central Nervous System Clinical Trials

Clinical Trials by Phase in E7 Countries

Clinical Trials in E7 Countries by Trial Status

Clinical Trials by Phase

In Progress Trials by Phase

Clinical Trials by Trial Status

Clinical Trials by End Point Status

Subjects Recruited Over a Period of Time

Clinical Trials by Sponsor Type

Prominent Sponsors

Top Companies Participating in Osteoarthritis Pain Therapeutics Clinical Trials

Prominent Drugs

Latest Clinical Trials News on Osteoarthritis Pain

Mar 07, 2016: Nuvo Pharmaceuticals Announces Results from European Ankle Sprain Study with Pennsaid 2%

Feb 16, 2016: Flexion Therapeutics Reports Primary Endpoint Met in Pivotal Phase 3 Trial of Zilretta in Knee Osteoarthritis

Feb 01, 2016: Carbylan Therapeutics Reports Top-Line Results From COR1.1 Clinical Trial of Hydros-TA in Patients With OA of the Knee

Dec 17, 2015: Kitov Pharmaceuticals Reports Additional Data from its Phase III Trial on the Beneficial Blood Pressure Effects of KIT-302

Dec 15, 2015: Kitov Pharmaceuticals' Pivotal Phase III Trial Successfully Meets Primary Efficacy Endpoint

Clinical Trial Profile Snapshots

Appendix

Abbreviations

Definitions

Research Methodology

Secondary Research

About us

Contact Us

Disclaimer

Source

List of Tables

Osteoarthritis Pain Therapeutics, Global, Clinical Trials by Region, 2016-

Osteoarthritis Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016-

Osteoarthritis Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016-

Osteoarthritis Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016-

Osteoarthritis Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2016-

Osteoarthritis Pain Therapeutics Clinical Trials, North America, Top Countries, 2016-

Osteoarthritis Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016-

Osteoarthritis Pain Therapeutics Clinical Trials, Central and South America, Top Countries, 2016-

Proportion of Osteoarthritis Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2016-

Osteoarthritis Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2016-

Osteoarthritis Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016-

Proportion of Osteoarthritis Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2016-

Osteoarthritis Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2016-

Osteoarthritis Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016-

Osteoarthritis Pain Therapeutics, Global, Clinical Trials by Phase, 2016-

Osteoarthritis Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2016-

Osteoarthritis Pain Therapeutics, Global, Clinical Trials by Trial Status, 2016-

Osteoarthritis Pain Therapeutics Clinical Trials, Global, by End Point Status, 2016-

Osteoarthritis Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015

Osteoarthritis Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016-

Osteoarthritis Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2016-

Osteoarthritis Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016-

Osteoarthritis Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016-

List of Figures

Osteoarthritis Pain Therapeutics, Global, Clinical Trials by Region (%), 2016-

Osteoarthritis Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016-

Osteoarthritis Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016-

Osteoarthritis Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016-

Osteoarthritis Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016-

Osteoarthritis Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2016-

Osteoarthritis Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016-

Osteoarthritis Pain Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016-

Proportion of Osteoarthritis Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2016-

Osteoarthritis Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2016-

Osteoarthritis Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016-

Proportion of Osteoarthritis Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2016-

Osteoarthritis Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2016-

Osteoarthritis Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016-

Osteoarthritis Pain Therapeutics, Global, Clinical Trials by Phase (%), 2016-

Osteoarthritis Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2016-

Osteoarthritis Pain Therapeutics, Global, Clinical Trials by Trial Status, 2016-

Osteoarthritis Pain Therapeutics Clinical Trials, Global, by End Point Status, 2016-

Osteoarthritis Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015

Osteoarthritis Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016-

Osteoarthritis Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2016-

Osteoarthritis Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016-

Osteoarthritis Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016-

Methodology
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
Johnson & Johnson
Pfizer Inc.
C. H. Boehringer Sohn AG & Co. KG
Eli Lilly and Company
Mundipharma International Ltd
Merck & Co., Inc.
Iroko Pharmaceuticals, LLC
GlaxoSmithKline Plc
Flexion Therapeutics, Inc.
Endo International Plc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll